Cefazolin sodium

头孢唑林钠

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameCefazolin sodium
Drug Alias Name唑啉头孢菌素Cephazolin sodiumCefazolinum先锋霉素Ⅴ先锋啉 +[12] 
ClassificationSmall molecules > Heterocyclic drugs > AntibioticsSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsSkin MelanomaSolid tumoursWounds and Injuries +[21] 
Global Approved IndicationsGram-Positive Bacterial InfectionsGram-Negative Bacterial InfectionsBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1973/10/04
Country/TerritoryCanadaUnited StatesSingapore +[18] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesRadboud University Medical CenterWashington University School Of MedicineCarmel Medical Center Inc +[7] 
Inactive CompaniesUniversity of California IrvineEunice Kennedy Shriver National Institute Of Child Health And Human DevelopmentGlaxosmithkline Plc +[11] 
Active IndicationsSkin MelanomaPostoperative ComplicationsHernia, Inguinal +[9] 
Inactive IndicationsSolid tumoursWounds and InjuriesObesity +[12] 

Other Information

ATC CodeJ01DB04
Related LinksWikipediaDrugBankKEGG